Cargando…
How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion
Anterior cervical discectomy and fusion (ACDF) is performed to relieve pain caused by degenerative disk disease and nerve obstruction. As an alternative to bone graft, autologous concentrated bone marrow aspirate (CBMA) is used to achieve vertebral fusion with a satisfactory success rate. This has b...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152872/ https://www.ncbi.nlm.nih.gov/pubmed/30248138 http://dx.doi.org/10.1371/journal.pone.0203714 |
_version_ | 1783357442796552192 |
---|---|
author | Chaput, Christopher D. Shar, Adam Jupiter, Daniel Hubert, Zach Clough, Bret Krause, Ulf Gregory, Carl A. |
author_facet | Chaput, Christopher D. Shar, Adam Jupiter, Daniel Hubert, Zach Clough, Bret Krause, Ulf Gregory, Carl A. |
author_sort | Chaput, Christopher D. |
collection | PubMed |
description | Anterior cervical discectomy and fusion (ACDF) is performed to relieve pain caused by degenerative disk disease and nerve obstruction. As an alternative to bone graft, autologous concentrated bone marrow aspirate (CBMA) is used to achieve vertebral fusion with a satisfactory success rate. This has been attributed in part to bone marrow-resident mesenchymal stromal cells (MSCs) with the capacity to differentiate into osteoblasts and generate bone tissue. To date, there has been no study comparing cellular yields, MSC frequencies and their osteogenic potential with ACDF outcome. Patients (n = 24) received ACDF with CBMA and allograft bone matrix. Colony forming unit fibroblast (CFU-F) and CFU-osteoblasts (CFU-O) assays were performed on CBMA samples to enumerate MSCs (CFU-F) and osteogenic MSCs (CFU-O). CFUs were normalized to CBMA volume to define yield and also to mononuclear cells (MNC) to define frequency. After 1-year, fusion rates were good (86.7%) with pain and disability improved. There was a negative relationship between MNC and CFU-F measurements with age of patient and CFU-Os negatively correlated with age in females but not males. Tobacco use did not affect CBMA but was associated with poorer clinical outcome. Surprisingly, we found that while high-grade fusion was not associated with CFU-O, it correlated strongly (p<0.0067) with CBMA containing the lowest frequencies of CFU-F (3.0x10(-6)–5.83x10(-5) CFU-F/MNC). MNC levels alone were not responsible for the results. These observations suggest that osteogenesis by human bone marrow is controlled by homeostatic ratio of MSCs to other cellular bone marrow components rather than absolute level of osteogenic MSCs, and that a lower ratio of MSCs to other cellular components in marrow tends to predict effective osteogenesis during ACDF. The results presented herein challenge the current dogma surrounding the proposed mechanism of MSCs in bone healing. |
format | Online Article Text |
id | pubmed-6152872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-61528722018-10-19 How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion Chaput, Christopher D. Shar, Adam Jupiter, Daniel Hubert, Zach Clough, Bret Krause, Ulf Gregory, Carl A. PLoS One Research Article Anterior cervical discectomy and fusion (ACDF) is performed to relieve pain caused by degenerative disk disease and nerve obstruction. As an alternative to bone graft, autologous concentrated bone marrow aspirate (CBMA) is used to achieve vertebral fusion with a satisfactory success rate. This has been attributed in part to bone marrow-resident mesenchymal stromal cells (MSCs) with the capacity to differentiate into osteoblasts and generate bone tissue. To date, there has been no study comparing cellular yields, MSC frequencies and their osteogenic potential with ACDF outcome. Patients (n = 24) received ACDF with CBMA and allograft bone matrix. Colony forming unit fibroblast (CFU-F) and CFU-osteoblasts (CFU-O) assays were performed on CBMA samples to enumerate MSCs (CFU-F) and osteogenic MSCs (CFU-O). CFUs were normalized to CBMA volume to define yield and also to mononuclear cells (MNC) to define frequency. After 1-year, fusion rates were good (86.7%) with pain and disability improved. There was a negative relationship between MNC and CFU-F measurements with age of patient and CFU-Os negatively correlated with age in females but not males. Tobacco use did not affect CBMA but was associated with poorer clinical outcome. Surprisingly, we found that while high-grade fusion was not associated with CFU-O, it correlated strongly (p<0.0067) with CBMA containing the lowest frequencies of CFU-F (3.0x10(-6)–5.83x10(-5) CFU-F/MNC). MNC levels alone were not responsible for the results. These observations suggest that osteogenesis by human bone marrow is controlled by homeostatic ratio of MSCs to other cellular bone marrow components rather than absolute level of osteogenic MSCs, and that a lower ratio of MSCs to other cellular components in marrow tends to predict effective osteogenesis during ACDF. The results presented herein challenge the current dogma surrounding the proposed mechanism of MSCs in bone healing. Public Library of Science 2018-09-24 /pmc/articles/PMC6152872/ /pubmed/30248138 http://dx.doi.org/10.1371/journal.pone.0203714 Text en © 2018 Chaput et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Chaput, Christopher D. Shar, Adam Jupiter, Daniel Hubert, Zach Clough, Bret Krause, Ulf Gregory, Carl A. How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion |
title | How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion |
title_full | How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion |
title_fullStr | How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion |
title_full_unstemmed | How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion |
title_short | How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion |
title_sort | how stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152872/ https://www.ncbi.nlm.nih.gov/pubmed/30248138 http://dx.doi.org/10.1371/journal.pone.0203714 |
work_keys_str_mv | AT chaputchristopherd howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion AT sharadam howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion AT jupiterdaniel howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion AT hubertzach howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion AT cloughbret howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion AT krauseulf howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion AT gregorycarla howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion |